Webcast CME

How to Obtain AMA PRA Category 1 Credit

  1. Complete the Activity.
  2. Complete the CME posttest (each question must be answered correctly).
  3. Log into your myCME account.
  4. Complete the credit and evaluation form.
  5. Print your personalized CME certificate.
  6. Credit can only be claimed once for this activity.

Technical Requirements

Advances in Biologic Therapies

 

Advances in Rheumatoid Arthritis

Print this Content

Release Date:   May 13, 2016
Expiration Date:  May 13, 2018

Estimated Time of Completion:   30 minutes

Description

Advances in Biologic Therapies is a webcast series that provides clinicians with a review of the use of biologic agents in the fields of rheumatology, dermatology, allergy, and infectious disease.

This webcast reviews advances in RA treatment and response predictors. Novel agents and toxicities will also be discussed.

Learning Objectives

  1. Describe what is new in RA treatment.
  2. Highlight what predicts response.
  3. Review the relationship between novel agents and novel toxicities.

Target Audience

These activities are directed to rheumatologists, dermatologists, allergists, infectious disease practitioners, internal medicine physicians, pulmonologists, nurse practitioners, physician assistants, and other health care professionals caring for patients with immunologic diseases.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Director and Faculty

Activity Director

Leonard H. Calabrese, DO
Professor of Medicine, Cleveland Clinic
Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

William Rigby, MD
Vice-Chair, Department of Medicine
Professor of Medicine & Microbiology
The Geisel School of Medicine at Dartmouth
Lebanon, NH

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:

Leonard H. Calabrese, DO
  GSK, Pfizer, Inc., Sanofi Aventis, UCB Consulting

AbbVie Pharmaceuticals, BMS, Genentech/Roche, Janssen Consulting; Teaching and Speaking

Crescendo
Teaching and Speaking
William Rigby, MD
  BMS Consulting
  Eli Lilly Consulting, Membership on Advisory Committee or Review Panels
  Genentech/Roche Consulting, Independent contractor (including contracted research), Membership on advisory committee or review panels, Teaching and Speaking
  Pfizer, Inc. Membership on Advisory Committee or review panels


The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:


AbbVie, Inc.
Amgen, Inc.
Bristol-Myers Squibb
Exagen Diagnostics
Genentech, Inc.
Pfizer, Inc.

This CME activity was produced by Cleveland Clinic Center for Continuing Education and
R.J. Fasenmyer Center for Clinical Immunology.

 
Copyright © 2000-2017 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 1950 Richmond Road, TR204, Lyndhurst, OH 44124
Copyright © 2000-2017 The Cleveland Clinic Foundation. All Rights Reserved.
Center for Continuing Education | 1950 Richmond Road, TR204, Lyndhurst, OH 44124